doi: 10.3389/fruro.2025.1565240 Received 22 January 2025 Accepted 31 March 2025 Published 25 April 2025 Volume 5 - 2025 Edited by Francisco Cruz, Faculty of Medicine University of Porto, Portugal Reviewed by Matteo Vittori, Policlinico Tor Vergata, Italy Joo Silva, So Joo University Hospital Center, Portugal Updates Copyright 2025 Morgia, Lo Giudice, Cimino, Reale, Largan, La Manna, Madonia, Tedde, Santaniello, Vespasiani, Zaganelli, Arnone, Cruciano, Carrino, Persico, Terrone, Malinaric, Minervini, Carini and Russo
doi:10.1016/j.bcp.2019.02.008 Dimet-Wiley A, Latham CM, Brightwell CR, et al
Future studies should address these gaps by incorporating experimental evidence and investigating personalized nutrition strategies to optimize carnitine intake while minimizing the health risks
Precision-Based Compounding: Key Differences PlushCare excels at speed and accessibilityideal for patients seeking quick GLP-1 access without geographic constraints
More research is needed to fully understand the effects of activating and blocking the GIP pathway on weight loss
This is generally attributed to tirzepatides dual GIP/GLP-1 mechanism, which appears to produce a stronger combined effect on appetite and blood sugar than semaglutides single-pathway action
)
